Singapore - Export of Heparin for Therapeutic Use

Since 2014, Singapore Export of Heparin for Therapeutic Use was down by 10.3% year on year. In 2019, the country was number 4 comparing other countries in Export of Heparin for Therapeutic Use with $425,870,600.82. Singapore is overtaken by France, which was ranked number 3 with $438,317,784.64 and is followed by Ireland with $193,558,300.78. China lead the ranking with $1,237,456,257.9 in 2019, a fall of 3% compared to 2018. Montenegro witnessed the best average annual growth at +490.8% per year, while Greenland recorded the worst performance at -78.9% per year.

Loading...

Date US Dollars
2019 425,870,600.82
2018 478,432,032.00
2017 328,692,992.00
2016 366,614,688.00
2015 521,643,520.00
Download all data from 1989 to 2019

How does Singapore rank in Export of Heparin for Therapeutic Use?

# 109 Countries US Dollars Last YoY 5‑years CAGR
1 #1
China
1,237,456,257.90 2019 -3.0 % +6.7 % View data
2 #2
United States
528,184,315.05 2019 +3.8 % -15.3 % View data
3 #3
France
438,317,784.64 2019 -7.7 % -7.0 % View data
4 #4
Singapore
425,870,600.82 2019 -11.0 % -10.3 % View data
5 #5
Ireland
193,558,300.78 2019 -10.3 % -0.9 % View data
Compare all 109 countries

Go Top